Aenova CEO Jan Kengelbach gives a statement on the current macroeconomic situation in the current issue of CHEManager (10/2022).

With the title "Fewer drugs at higher prices? The supply of pharmaceutical products in Europe is under pressure", Jan Kengelbach analyzes the consequences of the Ukraine war, the global disruptions to supply chains and energy supply, the enormous price increases accompanied by a highly volatile price situation, and the resulting challenges for CDMOs, customers and the supply of medicines to patients worldwide.